CHAIRMAN: DR. KHALID BIN THANI AL THANI
EDITOR-IN-CHIEF: PROF. KHALID MUBARAK AL-SHAFI

Qatar

HMC signs pact with Heidelberg Hospital

Published: 28 Jan 2018 - 09:47 am | Last Updated: 08 Nov 2021 - 11:17 am
H E Dr Hanan Mohamed Al Kuwari, Professor Dr Annette Grüters-Kieslich and Irmtraut Gürkan sign the agreement.

H E Dr Hanan Mohamed Al Kuwari, Professor Dr Annette Grüters-Kieslich and Irmtraut Gürkan sign the agreement.

The Peninsula

Doha: Hamad Medical Corporation (HMC) and Heidelberg University Hospital, an internationally renowned clinical and research institution in Germany, signed an agreement to enhance mutual collaborations in clinical, translational and basic research. 

The agreement was signed by H E Dr Hanan Mohamed Al Kuwari, Minister of Public Health, Professor Dr Annette Grüters-Kieslich, Chief Medical Director and Chairwoman of the Board of Heidelberg University Hospital, and Irmtraut Gürkan, Administrative Director and Vice-Chairwoman of the Board, Heidelberg University Hospital.

Dr Al Kuwari expressed her strong support for the deepening relationship between HMC and Heidelberg University Hospital, which will see further development of collaborative programs in medicine, especially in the fields of cancer research, technology transfer and training. 

“The purpose of the agreement is to promote opportunities for clinical and basic research collaborations, and to advance healthcare delivery in Qatar,” said Dr Al Kuwari. “We are very pleased to be entering into this important agreement with the Heidelberg University Hospital, as we work together to explore new ways to deliver better patient care,” she added.

The signing of the agreement was witnessed by senior leaders from medical and university institutions in Qatar and Germany and took place during the opening ceremony of the first Doha–Heidelberg Research Conference yesterday.

Professor Grüters-Kieslich, who also gave the keynote address at the opening ceremony, said: “An important focus in the development strategy of Heidelberg University Hospital is strengthening international networks in clinical research and medical care. For many years Hamad Medical Corporation has been an important partner for Heidelberg University Hospital and this agreement opens the way to take our relationship to a new level in the future.”

“Hamad already has a long-standing relationship with Heidelberg University Hosptial and this agreement will see advanced opportunities for joint collaboration, particularly for cancer research and training that will benefit a wide range of institutions in Qatar,” said Dr Saad Al Kaabi, Conference Organizing Committee Chairman and Chairman of the International Medical Affairs Office at HMC.

“The success of this first research conference between our two organisations has seen many clinicians, researchers, and academics come together to share knowledge and experience which will help inspire future collaboration opportunities,” added Dr Al Kaabi. 

Experts in the fields of Gastro-Intestinal (GI) cancer, neuro-oncology, and haematological malignancies, as well as paediatric cancers and genomic medicine in newborns, presented their research results during this two-day conference.

The National Center for Tumor Diseases NCT of the Heidelberg University Hospital is an international leader in cancer medicine and has a strong academic focus on improving cancer care through intensive clinical research.